Table 4 Characteristics of all study patients at baseline with two or more treatment contacts in the observation period
Total | Higher continuity of care | Lower continuity of care | p -value | |
|---|---|---|---|---|
Patients, n | 323 | 158 | 165 | |
Age in years, mean (SDa) | 45.2 (15.4) | 44.6 (14.0) | 45.9 (16.7) | 0.579 |
Sex, n (%) | ||||
female | 147 (45.5) | 69 (43.7) | 78 (47.3) | 0.516 |
male | 176 (54.5) | 89 (56.3) | 87 (52.7) | |
Migration background, n (%) | ||||
yes | 110 (34.3) | 61 (38.6 | 49 (30.1) | 0.107 |
no | 211 (65.7) | 97 (61.4) | 114 (69.9) | |
Main treatment diagnosis, n (%) | ||||
Organic, including symptomatic, mental disorders (ICD-10 F0) | 4 (1.2) | 1 (0.6) | 3 (1.8) | 0.001 |
mental and behavioral disorders due to psychoactive substance use (ICD-10 F1) | 107 (33.1) | 68 (43.0) | 39 (23.6) | |
general psychiatric disorders (ICD-10 F2-7) | 212 (65.6) | 89 (56.3) | 123 (74.5) | |
thereof: | ––– | ––– | ––– | ––– |
F2 schizophrenia, schizotypal and delusional disorders | 61 (28.8) | 26 (29.2) | 35 (28.5) | |
F3 mood (affective) disorders | 96 (45.3) | 40 (44.9) | 56 (45.5) | |
F4 neurotic, stress-related and somatoform disorders | 20 (9.4) | 12 (13.5) | 8 (6.5) | |
F6 disorders of adult personality and behavior | 35 (16.5) | 11 (12.4) | 24 (19.5) | |
Duration of psychiatric disease, n (%) | ||||
< 1 year | 69 (22.0) | 34 (22.1) | 35 (21.9) | 0.708 |
1–10 years | 123 (39.2) | 57 (37.0) | 66 (43.3) | |
> 10 years | 122 (38.9) | 63 (40.9) | 59 (36.9) | |
Hospital, n (%) | ||||
model hospital | 183 (56.7) | 138 (87.3) | 45 (27.3) | < 0.001 |
control hospital | 140 (43.3) | 20 (12.7) | 120 (72.7) | |